NIH: GLP-1 Treatment Late in Life Extends Lifespan in Animal Model
September 03, 2026
September 03, 2026
WASHINGTON, Sept. 3 (TNSjou) -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release:
* * *
GLP-1 treatment late in life extends lifespan in animal model
Medication produced benefits beyond what was achieved by calorie restriction alone.
-
A National Institutes of Health (NIH)-funded study has shown that the GLP-1 drug semaglutide extended lifespan in older, healthy mice b . . .
* * *
GLP-1 treatment late in life extends lifespan in animal model
Medication produced benefits beyond what was achieved by calorie restriction alone.
-
A National Institutes of Health (NIH)-funded study has shown that the GLP-1 drug semaglutide extended lifespan in older, healthy mice b . . .